Stanford, Epinomics Collaborate on Cancer Immunotherapy Research – GenomeWeb
|
Stanford, Epinomics Collaborate on Cancer Immunotherapy Research
GenomeWeb NEW YORK (GenomeWeb) – Stanford University's Park Institute for Cancer Immunotherapy and Epinomics announced they have agreed to collaborate on improving cancer immunotherapies by utilizing biomarkers and epigenomics technology. |
